Antigen-binding molecule comprising altered antibody variable region
US-12509524-B2 · Dec 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Feng Shu patents
Feng Shu is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Feng Shu |
| Total patents | 19 |
| First publication | Feb 4, 2021 |
| Latest publication | Dec 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Uses of dll3-targeting multispecific antigen-binding molecules
US-2024400721-A1 · Dec 5, 2024 · US
Bispecific anti-ccl2 antibodies
US-2024360208-A1 · Oct 31, 2024 · US
Bispecific anti-CCL2 antibodies
US-12103967-B2 · Oct 1, 2024 · US
Anti-C1S antibodies and methods of use
US-12084513-B2 · Sep 10, 2024 · US
Bispecific anti-ccl2 antibodies
US-2024117029-A1 · Apr 11, 2024 · US
Bispecific anti-ccl2 antibodies
US-2024083993-A1 · Mar 14, 2024 · US
Dll3-targeting multispecific antigen-binding molecules and uses thereof
US-2024010725-A1 · Jan 11, 2024 · US
Bispecific anti-CCL2 antibodies
US-11739142-B2 · Aug 29, 2023 · US
CD137- and DLL3-targeting multispecific antigen-binding molecules
US-11718672-B2 · Aug 8, 2023 · US
Recent patents
Latest publications not already listed above.
Immune activating multispecific antigen-binding molecules and uses thereof
US-2023147840-A1 · May 11, 2023 · US
Method for producing multispecific antigen-binding molecules
US-2023121511-A1 · Apr 20, 2023 · US
Dll3-targeting multispecific antigen-binding molecules and uses thereof
US-2022251201-A1 · Aug 11, 2022 · US
Antigen-binding molecule comprising altered antibody variable region
US-2022112296-A1 · Apr 14, 2022 · US
CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof
US-11274151-B2 · Mar 15, 2022 · US
Antigen-binding molecules capable of binding cd3 and cd137 but not simultaneously
US-2021388087-A1 · Dec 16, 2021 · US
Dll3-targeting multispecific antigen-binding molecules and uses thereof
US-2021301016-A1 · Sep 30, 2021 · US
Bispecific anti-ccl2 antibodies
US-2021188960-A1 · Jun 24, 2021 · US
Anti-c1s antibodies and methods of use
US-2021032365-A1 · Feb 4, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Chugai Pharmaceutical Co Ltd | 13 |
| Hoffmann La Roche | 6 |
| Chugai Seiyaki Kk | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/92 | 18 |
| C07K2317/31 | 17 |
| A61K2039/505 | 16 |
| C07K2317/565 | 16 |
| A61P35/00 | 14 |